title: Soluble complement receptor 1 is increased in patients with leukemia and after administration of granulocyte colony-stimulating factor.
abstract: Complement receptor type 1 is expressed by erythrocytes and most leukocytes. A soluble form is shed from the leukocytes and found in plasma (sCR1). sCR1 is a powerful inhibitor of complement. We report an increased sCR1 in the plasma of leukemia patients, up to levels producing measurable complement inhibition. Half of the 180 patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL) had sCR1 levels above the normal range. The highest levels were observed in T-ALL (17 patients). The complement function of a T-ALL serum was improved by blocking sCR1 with a specific mAb (3D9). Measurements in 16 peripheral stein cell donors before and after granulocyte colony-stimulating factor (G-CSF) administration showed an increase in sCR1 (before, 43.8+/-15.4; at day 5, 118.3+/-44.7 ng/mL; P < 0.0001). This increase paralleled the increase in total leukocyte counts and was concomitant with de novo leukocyte mRNA CR1 expression in all three individuals tested. Whether pharmacological intervention may be used to up-regulate sCR1 so as to inhibit complement in vivo should be further investigated.
authors.affiliation: Immunonephrologie Labor, Department Forschung, Kantonsspital Basel, Switzerland. Sadallah@ubaclu.unibas.ch
authors.forename: S
authors.initials: S
authors.lastname: Sadallah
authors.forename: E
authors.initials: E
authors.lastname: Lach
authors.forename: S
authors.initials: S
authors.lastname: Schwarz
authors.forename: A
authors.initials: A
authors.lastname: Gratwohl
authors.forename: O
authors.initials: O
authors.lastname: Spertini
authors.forename: J A
authors.initials: JA
authors.lastname: Schifferli
mesh_terms: D000818:Animals; D003165:Complement System Proteins / Q000502:physiology; D004797:Enzyme-Linked Immunosorbent Assay; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D019041:L-Selectin / Q000097:blood; D007945:Leukemia, Lymphoid / Q000097:blood* / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000097:blood* / Q000188:drug therapy*; D011817:Rabbits; D017463:Receptors, Complement 3b / Q000097:blood*; D012189:Retrospective Studies; D012995:Solubility; D014019:Tissue Donors
chemical_list: D017463:Receptors, Complement 3b; D019041:L-Selectin; D016179:Granulocyte Colony-Stimulating Factor; D003165:Complement System Proteins